On August 4, 2022, Exzell Pharma Inc. (“Exzell”), a Canadian pharmaceutical business, announced its sale to Biolab Pharma Ltd. (“Biolab”). Biolab is a subsidiary of Biolab Sanus Farmacêutica Ltda., with headquarters in Brazil.
Fasken advised Exzell with a team led by Wojtek Baraniak, and that included Kevin Yip (Tax), Alexis Shamess (Corporate), Armand Benitah and Nathan Haldane (Intellectual Property), Robert Iaccino and Ruby Cammarano (Real Estate).
Jurisdiction
- Ontario
